1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N1380R
    Guaiacol (Standard)

    愈创木酚 (标准品);

    Inhibitor
    Guaiacol (Standard) 是 Guaiacol 的分析标准品。本产品用于研究及分析应用。Guaiacol 是一种酚类化合物,抑制 LPS 刺激的 COX-2 表达和 NF-κB 激活。具有抗炎活性。
    Guaiacol (Standard)
  • HY-P1860A
    TNF-α (31-45), human TFA Activator
    TNF-α (31-45), human TFA 是一种有效的 NF-kB 通路激活剂,也是一种促炎细胞因子,可诱导坏死或凋亡。TNF α 通过 TNFR2 刺激 NF-κB 通路,促进癌症生长、侵袭和转移。
    TNF-α (31-45), human TFA
  • HY-N9942
    Physalin A Inhibitor 99.63%
    Physalin A 是一种具有生物活性的醉茄内酯。Physalin A 在椎间盘退变模型中表现出抗炎、抗纤维化和改善自噬 (autophagy) 的作用。Physalin A 具有抗肿瘤活性,可诱导细胞凋亡 (apoptosis),ROS 产生和 G2/M 期细胞周期阻滞。此外。Physalin A 可显著提高醌还原酶活性,来提高解毒酶的表达。
    Physalin A
  • HY-148552
    Anti-inflammatory agent 35 Inhibitor 99.77%
    Anti-inflammatory agent 35 (化合物 5a27) 是一种口服有效的姜黄素类似物,具有抗炎活性。Anti-inflammatory agent 35 可阻断丝裂原活化蛋白激酶 (MAPK) 信号和 NF-kB 的核易位。Anti-inflammatory agent 35 还抑制黄中性粒细胞浸润和促炎细胞因子产生。Anti-inflammatory agent 35 在体内研究中显著减轻脂多糖 (LPS) 诱导的急性肺损伤 (ALI)。
    Anti-inflammatory agent 35
  • HY-W357818
    Glycinexylidide

    甘氨酸二甲基苯胺

    Inhibitor
    Glycinexylidide (GX) 是 Lidocaine 的活性代谢物。Lidocaine 是一种局部活性剂,可抑制或缓解疼痛,可抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 还可减少胃癌细胞的生长,迁移和侵袭。Glycinexylidide 有用于麻醉、癌症以及心血管疾病的研究潜力。
    Glycinexylidide
  • HY-168328
    FKK6 Inhibitor 99.14%
    FKK6 是孕烷 X 受体 (PXR) 的选择性激动剂,EC50 为 1.2 µM。FKK6 与血浆蛋白具有良好的亲和性,并且在人类微粒体中具有良好的代谢特性。FKK6 抑制 PXR 相关的 NF-κB 信号通路,抑制炎症因子的表达,并在小鼠模型中对 DSS (HY-116282) 诱发的结肠炎表现出抗炎活性。
    FKK6
  • HY-111954
    (+)-Erinacin A 99.97%
    (+)-Erinacin A (Erinacine A) 是一种可从猴头菌中分离出的氰烷二萜,具有抗癌,抗炎和神经保护活性。(+)-Erinacin A 能够通过激活了外源性和内源性凋亡 (apoptosis) 途径引发癌细胞死亡。(+)-Erinacin A 也能抑制 NO 合成酶 (iNOS) 的表达和硝基酪氨酸的产生来发挥炎症和神经保护作用,从而减少缺血性脑损伤。
    (+)-Erinacin A
  • HY-N3796
    Echinulin Activator 98.63%
    Echinulin (Echinuline) 是一种带有三苯甲基化吲哚部分的环状二肽。 Echinulin 有助于激活 T 细胞亚群,从而导致 NF-κB 活化。Echinulin 通过 NF-κB 途径发挥其免疫作用。Echinulin 具有作为免疫抑制剂的潜力。
    Echinulin
  • HY-121955
    FW1256 Inhibitor
    FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),具有有效的抗炎作用,并可用于癌症和心血管疾病的研究。
    FW1256
  • HY-B1971R
    Deltamethrin (Standard)
    Deltamethrin (Standard) 是 Deltamethrin 的分析标准品。本产品用于研究及分析应用。Deltamethrin (Decamethrin) 是一种具有口服活性的人工合成的拟除虫菊酯类杀虫剂。Deltamethrin通过抑制 Nrf2/HO-1 通路诱导氧化应激,导致炎症反应和细胞凋亡 (apoptosis),通过诱导细胞凋亡 (apoptosis) 而发挥抗肿瘤作用,可广泛用于害虫防治。
    Deltamethrin (Standard)
  • HY-170669
    PROTAC XPO1 degrader-1 Inhibitor
    PROTAC XPO1 degrader-1 (Compound 2c) 是一种 XPO1 降解剂。PROTAC XPO1 degrader-1 具有抗细胞增殖作用,还能诱导细胞凋亡 (Apoptosis),抑制 NF-κB 活性,并导致细胞周期阻滞于 G1 期。PROTAC XPO1 degrader-1 可以用于血液系统恶性肿瘤的研究 (粉色: 靶蛋白配体 (HY-170672); 黑色: Linker (HY-W010525); 蓝色: E3 连接酶配体 (HY-170671); E3 连接酶配体-Linker 偶联物 (HY-170673))。
    PROTAC XPO1 degrader-1
  • HY-Y0586
    2,4,5-Trimethoxybenzoic acid Inhibitor 99.98%
    2,4,5-Trimethoxybenzoic acid (Asaronic acid) 是紫苏提取物中的一种化合物。2,4,5-Trimethoxybenzoic acid 抑制 LPS (HY-D1056) 诱导的炎症反应,抑制 NF-κBSTAT 信号通路的激活。2,4,5-Trimethoxybenzoic acid 抑制 M1 巨噬细胞表型介导的糖尿病炎症。
    2,4,5-Trimethoxybenzoic acid
  • HY-155765
    Anti-inflammatory agent 51 Inhibitor 98.08%
    Anti-inflammatory agent 51 (compound 11d) 是一种酰胺/磺酰胺衍生物,具有抗炎活性。Anti-inflammatory agent 51 抑制 NF-κB 激活,具有用于急性肺损伤和溃疡性结肠炎研究的潜力。
    Anti-inflammatory agent 51
  • HY-N2065R
    Withaferin A (Standard)

    醉茄素A (Standard)

    Inhibitor
    Withaferin A (Standard) 是 Withaferin A 的分析标准品。本产品用于研究及分析应用。Withaferin A 是从睡茄中分离到的甾体内酯,可以抑制 NF-kB 的活性,靶作用于波形蛋白 (vimentin),具有抗炎,抗肿瘤等功效。Withaferin A 是内皮蛋白 C 受体 (EPCR) 脱落的抑制剂。
    Withaferin A (Standard)
  • HY-122949
    Momordicine I Inhibitor
    Momordicine I 是一种葫芦烷型三萜类化合物。Momordicine I 通过促进细胞凋亡 (apoptosis) 和损害线粒体氧化磷酸化抑制胶质瘤生长。Momordicine I 抑制糖酵解、脂质代谢,诱导 HNC 细胞自噬 (autophagy),从而抑制头颈癌的生长。Momordicine I 通过抑制 PLA2G6DGK-ζ 减轻异丙肾上腺素诱导的心肌细胞肥大。Momordicine I 通过上调 NO、抑制血管紧张素转换酶 (ACE) 活性、激活 PI3K/Akt 通路、减少氧化应激和炎症发挥其心血管益处。Momordicine I 可抑制 AKT1IL-6SRC,暗示其应用于 2 型糖尿病的潜力。
    Momordicine I
  • HY-N2106
    Dehydroevodiamine

    去氢吴茱萸碱

    99.93%
    Dehydroevodiamine 是从吴茱萸 Evodiae Fructus 中分离出的喹唑啉生物碱,对豚鼠心室肌细胞具有抗心律失常作用。Dehydroevodiamine 抑制 LPS 诱导的小鼠巨噬细胞中 iNOSCOX-2PGE2NF-κB 的表达。
    Dehydroevodiamine
  • HY-34411
    Phloroglucinol Inhibitor 99.71%
    Phloroglucinol 是一种有效的 NIK 抑制剂,具有抗氧化和抗炎活性。Phloroglucinol 抑制核因子-κB (NF-κB)、细胞外信号调节激酶 (ERK) 和 c-Jun N-末端激酶 (JNK) 等信号通路,清除活性氧 (ROS) ,降低炎症介质 (如 TNF-α、IL-1β、IL-6、PGE2) 和基质金属蛋白酶 (MMPs) 的表达。Phloroglucinol 有望用于关节炎、动脉粥样硬化等慢性炎症相关疾病的研究。
    Phloroglucinol
  • HY-153516
    NIK-IN-2 Inhibitor 99.00%
    NIK-IN-2 (compound 1) 是 NF-κB 诱导激酶 (NIK) 的有效抑制剂,其 pIC50 为 7.4。NIK-IN-2 在癌症研究中发挥着重要作用。
    NIK-IN-2
  • HY-101410R
    SDMA (Standard)

    对称二甲基精氨酸 (Standard)

    Activator
    SDMA (Standard)是 SDMA 的分析标准品。本产品用于研究及分析应用。SDMA (Symmetric dimethylarginine)是一氧化氮 (NO) 合酶活性的内源性抑制剂。SDMA 是一种新的肾脏生物标志物,可以比传统的肌酐检测更早地诊断肾脏疾病。
    SDMA (Standard)
  • HY-W005130
    2,4,6-Trihydroxybenzaldehyde

    2,4,6-三羟基苯甲醛

    Inhibitor 99.93%
    2,4,6-Trihydroxybenzaldehyde 是一种具有口服活性的 NF- B 抑制剂。2,4,6-Trihydroxybenzaldehyde 具有抗肿瘤活性、抗癌细胞增殖活性和抗肥胖活性。
    2,4,6-Trihydroxybenzaldehyde
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.